CITIGROUP INC - AEGLEA BIOTHERAPEUTICS INC ownership

AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 89 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of AEGLEA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2022$0
-100.0%
633
-87.8%
0.00%
Q2 2022$3,000
-70.0%
5,176
+19.8%
0.00%
Q1 2022$10,000
-82.1%
4,319
-63.7%
0.00%
Q4 2021$56,000
-1.8%
11,894
+66.7%
0.00%
Q3 2021$57,000
+62.9%
7,133
+43.1%
0.00%
Q2 2021$35,000
+6.1%
4,983
+21.2%
0.00%
Q1 2021$33,000
-58.2%
4,111
-59.2%
0.00%
Q4 2020$79,000
+132.4%
10,076
+107.8%
0.00%
Q3 2020$34,000
-57.5%
4,849
-44.1%
0.00%
Q2 2020$80,000
+81.8%
8,668
-7.3%
0.00%
Q1 2020$44,000
-24.1%
9,355
+22.9%
0.00%
Q4 2019$58,000
+190.0%
7,610
+191.2%
0.00%
Q3 2019$20,000
-60.8%
2,613
-64.9%
0.00%
Q2 2019$51,000
+10.9%
7,441
+30.5%
0.00%
Q1 2019$46,000
+43.8%
5,702
+35.6%
0.00%
Q4 2018$32,000
-25.6%
4,204
-6.1%
0.00%
Q3 2018$43,000
+72.0%
4,478
+91.3%
0.00%
Q2 2018$25,0002,3410.00%
Other shareholders
AEGLEA BIOTHERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Yu Fan 112,044$532,0006.17%
Aisling Capital Management LP 1,691,151$8,033,0002.83%
Bain Capital Life Sciences Investors, LLC 2,847,689$13,527,0001.07%
GREAT POINT PARTNERS LLC 910,251$4,324,0000.96%
Samsara BioCapital, LLC 883,720$4,198,0000.81%
Sio Capital Management, LLC 498,500$2,368,0000.71%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 245,678$1,167,0000.53%
Nantahala Capital Management 2,813,560$13,364,0000.47%
Altium Capital Management LP 293,764$1,395,0000.38%
Lion Point Capital, LP 300,000$1,425,0000.38%
View complete list of AEGLEA BIOTHERAPEUTICS INC shareholders